Skip to main content
Health & Medicine

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

| Source: Lancet (London, England)

WHO grade 2 atypical meningioma is a primary brain tumour with a high risk of recurrence even after complete surgical resection. The role of adjuvant radiotherapy remains uncertain. We aimed to assess whether adjuvant radiotherapy reduces recurrence compared with observation in patients with a newly diagnosed atypical meningioma who have undergone complete surgical resection. ROAM/EORTC-1308 was an international, multicentre, open-label, phase 3, randomised controlled trial, conducted at 58 hosp

WHO grade 2 atypical meningioma is a primary brain tumour with a high risk of recurrence even after complete surgical resection. The role of adjuvant radiotherapy remains uncertain. We aimed to assess whether adjuvant radiotherapy reduces recurrence compared with observation in patients with a newly diagnosed atypical meningioma who have undergone complete surgical resection. ROAM/EORTC-1308 was an international, multicentre, open-label, phase 3, randomised controlled trial, conducted at 58 hospitals and academic centres in 11 countries. Eligible sites had appropriate multidisciplinary expertise, neurosurgery, and radiotherapy facilities. Patients aged 16 years or older who had undergone a surgeon-assessed complete surgical resection of newly diagnosed atypical meningioma were randomly assigned (1:1) to adjuvant radiotherapy or observation. Randomisation was done using a web-based interface using random variable blocks of sizes two and four, stratified by location (UK or non-UK). Participants assigned to the radiotherapy group received fractionated external-beam intensity-modulated radiotherapy at a total dose of 60 Gy in 30 fractions over 6 weeks. Participants were followed up for a minimum of 4 years. The primary outcome was disease-free survival, defined as time from surgery to MRI-confirmed recurrence or death due to any cause, analysed in all randomly assigned participants in their assigned treatment group. Harms analysis was done in the as-treated population. The trial was registered with ISRCTN, ISRCTN71502099, and has completed. Between April 28, 2016, and May 21, 2021, 990 patients were assessed for eligibility, 157 of whom were randomly assigned to radiotherapy (n=78) or observation (n=79). Median age was 57·40 years (IQR 49·09-66·93); 84 (54%) participants were female and 73 (46%) were male. At a median follow-up of 64 months (IQR 50-75), meningioma recurrence occurred in 11 (14%) of 78 participants in the radiotherapy group and 24 (30%) of 79 in the observation group. 5-year disease-free survival was 79·9% (95% CI 67·6-87·9) in the radiotherapy group and 64·3% (51·9-74·2) in the observation group (absolute difference 15·6% percentage points [95% CI 0·6-30·5]). Disease-free survival was improved in the radiotherapy group compared with the observation group (hazard ratio 0·51 [95% CI 0·27-0·97]; p=0·0396). Grade 2 or 3 radiation-related serious adverse events occurred in five (8%) of 66 participants in the radiotherapy group, with no treatment-related deaths. Our findings suggest that adjuvant radiotherapy should be considered in patients with atypical meningioma after complete surgical resection of atypical meningioma when the prevention of recurrence is valued higher than the potential delayed adverse effects of radiotherapy. This practice will benefit patients by reducing meningioma recurrence. Decisions should be based on individual discussion with the patient. National Institute for Health and Care Research Health Technology Assessment programme, the European Organisation for Research and Treatment of Cancer Brain Tumour Group and Radiation Oncology Group, and the Heath Research and Medical Research Council of Australia.

Read the original source →

Related Topics

Related Stories

Health & Medicine

Homeostatic control of stem cell activity during intestinal regeneration.

Stem cells proliferate rapidly to maintain tissue turnover during regeneration, yet the mechanisms preventing hyperproliferation remain unclear. Here, we identified nuclear factor Y (NF-Y) as a transcriptional repressor that maintains intestinal stem cell (ISC) quiescence. NF-Y restricts ISC proliferation by occupying the promoters of epidermal growth factor receptor (EGFR) signaling components, including Egfr , Mkp3 , Raf , Ras , and pnt , through regulation dependent on the histone acetyltrans

Continue reading
Health & Medicine

Spatial transcriptomics reveals organizational properties of the mouse spinal cord and alterations in neuropathic pain.

The spinal cord integrates diverse somatosensory inputs and executes motor outputs through anatomically and functionally distinct circuits. Here, we employed spatially resolved single-cell transcriptomic profiling of the adult mouse spinal cord to gain insights into the organizational logic of the spinal cord. Our results reveal distinct spatial and laminar distributions of neuronal subtypes, including axial level and sex-specific differences. Many neuronal subtypes exhibit lamina-specific somat

Continue reading
Health & Medicine

Acute degradation of Pumilio proteins reveals a biphasic posttranscriptional regulatory hierarchy in embryonic stem cell fate decision.

Posttranscriptional regulation is critical for mammalian embryogenesis yet has been underexplored. We previously showed that RNA-binding Pumilio proteins (Pum1/2) are essential for early mouse embryogenesis and embryonic stem cell (ESC) functions. Here, using acute protein degradation systems combined with time-resolved RNA sequencing and enhanced crosslinking and immunoprecipitation, we delineate a two-phase regulatory hierarchy modulated by Pum1/2 in mouse ESCs. The first phase, occurring with

Continue reading
Health & Medicine

Elastic interactions of mechanically polarizable cells.

Cells mechanically interact through the deformations they generate in their surrounding extracellular matrix. We present an analytical theory of the elastic interactions between cells that actively adapt their forces in response to local deformations of their environment. Cells are represented as localized contractile force generators, modeled as polarizable point force dipoles, whose adaptive forces are determined self-consistently with those of surrounding cells. Analysis of the associated ela

Continue reading
Health & Medicine

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection.

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potent

Continue reading